Thorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for 10.20 Per Share in Cash

THRNDelisted Stock  USD 6.40  0.48  8.11%   
About 55% of Thorne HealthTech's investors are presently thinking to get in. The analysis of current outlook of investing in Thorne HealthTech suggests that some traders are interested regarding Thorne HealthTech's prospects. Thorne HealthTech's investing sentiment overview a quick insight into current market opportunities from investing in Thorne HealthTech. Many technical investors use Thorne HealthTech stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Thorne HealthTech, Inc. , a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it has entered into a definitive agreement under which L Catterton, a leading global consumer-focused investment firm, will commence a tender offer to acquire all outstanding shares of common stock of Thorne for 10.20 per share in cash. The transaction value of approximately 680 million represents a 94 percent premium

Read at finance.yahoo.com
Yahoo News
  

Thorne HealthTech Fundamental Analysis

We analyze Thorne HealthTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Thorne HealthTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Thorne HealthTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Asset

Total Asset Comparative Analysis

Thorne HealthTech is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Thorne HealthTech Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Thorne HealthTech stock to make a market-neutral strategy. Peer analysis of Thorne HealthTech could also be used in its relative valuation, which is a method of valuing Thorne HealthTech by comparing valuation metrics with similar companies.

Peers

Thorne HealthTech Related Equities

POSTPost Holdings   0.42   
0%
10.0%
NOMDNomad Foods   0.18   
0%
4.0%
ASBFFAssociated British   0.00   
0%
0%
JJSFJ J   0.40   
9.0%
0%
JBSSJohn B   0.60   
14.0%
0%
NATRNatures Sunshine   0.86   
20.0%
0%
LANCLancaster Colony   1.02   
24.0%
0%
CENTCentral Garden   1.09   
26.0%
0%
CENTACentral Garden   1.11   
26.0%
0%
SMPLSimply Good   1.29   
30.0%
0%
SENEASeneca Foods   2.16   
51.0%
0%
BRBRBellring Brands   2.20   
52.0%
0%
RGFReal Good   4.17   
100.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Thorne Stock

If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance